MEDICAL TECHNOLOGY & INNOVATIONS INC /FL/
3, 2000-02-29
AMUSEMENT & RECREATION SERVICES
Previous: ENDEAVOR SERIES TRUST, N-30D, 2000-02-29
Next: TENGTU INTERNATIONAL CORP, 10QSB, 2000-02-29





                                     FORM 3
OMB Approval
OMB Number 3235-0104
Expires: February 1, 1994

                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

     INITIAL  STATEMENT OF BENEFICIAL  OWNERSHIP OF SECURITIES Filed pursuant to
Section  16(a) of the  securities  Exchange  Act of 1934,  Section  17(a) of the
Public  Utility  Holding  Company Act of 1935 or Section 30(f) of the Investment
Company Act of 1940

___ Check if no longer subject to Section 16, Form 4 or Form 5,
       Obligation may continue.  See Instructions
_X_ Form 3 Holdings Reported
___ Form 4 Transaction


<TABLE>
<S>                                                    <C>
1. Name and Address of Reporting Person:                DelVecchio, Joseph L.
                                                        615 Centerville Road
                                                        Lancaster, PA    17601
2. Date of Event Requiring Statement:                   02/01/2000
3. IRS or SSN of Reporting Person (Voluntary):
4. Issuer Name and Ticker or Trading Symbol:            MTEN
5. Relation of Reporting Person to Issuer               X Director
                                                          10% owner
                                                        X Officer (Title): Exec.  V.P.
                                                                           and  COO
                                                        _ Other (Specify)
6. If Amendment, Date of Original:
7.      X Filed by One Reporting Person.
        _ Filed by more than One Reporting Person.
</TABLE>


TABLE I - NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED

<TABLE>
<S>                                     <C>
1. Title of Security:                   Common Stock
2. Amount of Securities
Beneficially Owned:                     795,000
3. Ownership Form;
Direct (D) or Indirect (I):             D
4. Nature of Indirect Beneficial
Ownership:
</TABLE>

*If the form is filed by more than one Reporting Person, see instruction 5(b)(v)
Reminder:  Report on a separate Line for each class of  securities  beneficially
owned directly or indirectly.




<PAGE>




TABLE II - DERIVATIVE SECURITIES BENEFICIALLY OWNED

1.  Title of Derivative Security:
2. Date Exercisable and Expiration Date:
3. Title and Amount of Underlying Securities:
4. Conversion or Exercise Price of Derivative
   Securities:
5. Ownership of Derivative Securities;
   Direct (D) or Indirect (I):
6. Nature of Indirect Beneficial Ownership:

EXPLANATION OF RESPONSES:






/s/ Joseph L.  DelVecchio                     Date: 02/01/2000
- --------------------------------
Joseph L.  DelVecchio

**Signature of Reporting Person
**Intentional  misstatements or omissions of facts  constitute  Federal Criminal
Violations. See Sections 18 U.S.C. 1001, 15 U.S.C. 78ff(a).





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission